Search

Search Constraints

You searched for: Author/Creator Vekemans, Johan

Search Results

2. A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India. (December 2021)

3. A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS, S/AS01E and RTS, S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive Adults. (20th July 2020)

4. Clinical trials of tuberculosis vaccines in the era of increased access to preventive antibiotic treatment. Issue 4 (April 2023)

5. Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. Issue 10282 (10th April 2021)

6. Efficacy of RTS, S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial. Issue 9 (September 2022)

8. Immune response to the hepatitis B antigen in the RTS, S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial. Issue 6 (3rd June 2018)

9. Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial. (January 2022)

10. Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: A World Health Organization Action Framework. (25th January 2021)